Search research articles
Contact Us
Filters
Showing results (141-150 of 289) with videos related to
Page
of 29
Sort By:
Managed Care Quarterly
|
March 17, 2001
Understanding costs of home and community based services
T M Waters, O Almagor, S Finkel, et al.
Journal of Child Neurology
|
September 1, 2007
Consensus statement for standard of care in spinal muscular atrophy
Ching H Wang, Richard S Finkel, Enrico S Bertini, et al.
Neuromuscular Disorders : NMD
|
March 30, 2021
Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen
Drew MacCannell, Zdenek Berger, Lilly East, et al.
Annals of Neurology
|
December 7, 2007
DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy
Olga L Gurvich, Therese M Tuohy, Michael T Howard, et al.
Journal of Neuromuscular Diseases
|
February 22, 2020
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1
Sally Dunaway Young, Jacqueline Montes, Rachel Salazar, et al.
Neuromuscular Disorders : NMD
|
July 26, 2017
Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials
Jacob J Gissy, Teresa Johnson, Deborah J Fox, et al.
Muscle & Nerve
|
April 6, 2022
Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States
Basil T Darras, Sabrina Guye, Janine Hoffart, et al.
Neuromuscular Disorders : NMD
|
January 16, 2010
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability
A M Glanzman, E Mazzone, M Main, et al.
Clinical Biomechanics (Bristol, Avon)
|
March 20, 2012
Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease
Joshua Burns, Robert Ouvrier, Tim Estilow, et al.
Journal of Neuromuscular Diseases
|
November 20, 2018
Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy
Erika Finanger, Krista Vandenborne, Richard S Finkel, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 289) with videos related to
Sort By:
Page
of 29
Managed Care Quarterly
|
March 17, 2001
Understanding costs of home and community based services
T M Waters, O Almagor, S Finkel, et al.
Journal of Child Neurology
|
September 1, 2007
Consensus statement for standard of care in spinal muscular atrophy
Ching H Wang, Richard S Finkel, Enrico S Bertini, et al.
Neuromuscular Disorders : NMD
|
March 30, 2021
Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen
Drew MacCannell, Zdenek Berger, Lilly East, et al.
Annals of Neurology
|
December 7, 2007
DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy
Olga L Gurvich, Therese M Tuohy, Michael T Howard, et al.
Journal of Neuromuscular Diseases
|
February 22, 2020
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1
Sally Dunaway Young, Jacqueline Montes, Rachel Salazar, et al.
Neuromuscular Disorders : NMD
|
July 26, 2017
Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials
Jacob J Gissy, Teresa Johnson, Deborah J Fox, et al.
Muscle & Nerve
|
April 6, 2022
Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States
Basil T Darras, Sabrina Guye, Janine Hoffart, et al.
Neuromuscular Disorders : NMD
|
January 16, 2010
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability
A M Glanzman, E Mazzone, M Main, et al.
Clinical Biomechanics (Bristol, Avon)
|
March 20, 2012
Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease
Joshua Burns, Robert Ouvrier, Tim Estilow, et al.
Journal of Neuromuscular Diseases
|
November 20, 2018
Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy
Erika Finanger, Krista Vandenborne, Richard S Finkel, et al.
Page
of 29